Healthcare

Healthcare

Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree

Photo via Spencer Jones/GHI//UCG/Universal Images Group/Newscom

The highest dose of a single injection reduced cholesterol levels by 62% in patients, according to Eli Lilly’s recently published study.

2 min read

Photo via JOHN ANGELILLO/UPI/Newscom

Healthcare

Eli Lilly Says Next-Gen Weight Loss Drug Shows Results on Par with Bariatric Surgery

Eli Lilly said on Thursday its retatrutide cleared a late-stage trial, helping patients lose an average 29% of their weight across 80 weeks.

1 min read
Photo via Kris Tripplaar/Sipa USA/Newscom

Healthcare

Natera’s Stronghold in Cancer Recurrence Tests Prompts Wood’s Ark to Expand Stake

Natera’s flagship product, Signatera is a personalized MRD blood test that detects cancer recurrence by identifying the unique DNA mutations.

2 min read
Photo via Stephane Lemouton/SIPA/Newscom

Artificial Intelligence

AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding

Isomorphic previously raised $600 million in external funding last year, which was also led by NYC’s Thrive Capital.

1 min read

Healthcare

Hantavirus Trade Stalls as Officials Say Risk to Public Ranges from “Low” to “Very, Very Low”

Photo via Michael Brochstein/ZUMAPRESS/Newscom

Evercore ISI analysts said in a note they “see no meaningful revenue opportunity” for Moderna in hantaviruses.

2 min read

Healthcare

UnitedHealth Boosts Profit Forecast Without Committing to Medicare Obesity Drug Coverage

Photo via Steven Garcia/ZUMAPRESS/Newscom

The company now expects 2026 adjusted earnings of more than $18.25 per share, a jump from the $17.75 per share it previously forecasted.

2 min read

Healthcare

Merck Preps for End of Keytruda Exclusivity with $6.7B Deal for Leukemia Treatment

Photo via Anthony Behar/Sipa USA/Newscom

The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.